M. Isobe, SCINTIGRAPHIC IMAGING OF MHC CLASS-II ANTIGEN INDUCTION IN MOUSE KIDNEY ALLOGRAFTS - A NEW APPROACH TO NONINVASIVE DETECTION OF EARLY REJECTION, Transplant international, 6(5), 1993, pp. 263-269
Mice with kidney transplants were investigated to determine whether ea
rly kidney allograft rejection could be detected by radioimmune scinti
graphy targeting major histocompatibility complex (MHC) class II antig
ens induced on donor organ cells. Allografts from C3H/He (H2k) donors
were transplanted into BALB/c (H2d) recipients. Each mouse was injecte
d intravenously with 100 muCi of I-123-labeled anti-MHC class II monoc
lonal antibody (mAb; Y17, anti-IE(k)) 16 h before scintigraphy. After
imaging, mice were sacrificed for tissue counting and histopathologica
l examination. Radiotracer uptake in the nontreated allografts increas
ed starting on the 3rd day after transplantation, peaked at around the
6th day, and then gradually decreased. Rejecting allografts with only
focal perivascular mononuclear cell infiltration could be identified
by scintigraphy. However, allografted mice without evidence of rejecti
on and isografted mice did not show an increase in radiotracer uptake.
Rejecting BALB/c kidney transplanted into C3H/He mice did not show an
increase in Y17 mAb uptake, suggesting that class II antigens induced
on donor kidneys are solely responsible for the mAb uptake in positiv
e scintigrams of rejecting allografts. Five allografted mice were trea
ted with anti-CD3 mAb and cyclosporin starting 3-9 days after transpla
ntation. Radiotracer uptake decreased after 4 weeks of treatment and i
ncreased 2 weeks after the cessation of immunosuppressive treatment, r
eflecting suppression and recurrence of rejection, as determined by hi
stological examination. These changes could be followed scintigraphica
lly. We conclude that changes in class II antigen expression can be as
sessed by the I-123-labeled anti-MHC class II antigen mAb and that it
is a sensitive and noninvasive method for detecting kidney allograft r
ejection.